Skip to main content
Figure 1 | Journal of Clinical Movement Disorders

Figure 1

From: Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials

Figure 1

IRLS Rating Scale total score change from baseline in DA-naive vs DA-exposed patients (week 12). Change from baseline reported as the LS mean change from baseline. DA, dopamine agonist; Diff, mean treatment difference between DA-naive and DA-exposed treatment groups; GEn, gabapentin enacarbil; IRLS, International Restless Legs Syndrome; LS, least squares; SE, standard error.

Back to article page